These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2852381)

  • 41. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
    Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical and histopathological studies on radiotherapy for hypopharyngeal carcinoma--factors determining the outcome of the therapy].
    Takashima H; Amatsu M
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):906-15. PubMed ID: 6619640
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiotherapy of the resected mandible following stainless steel plate fixation.
    Scher N; Poe D; Kuchnir F; Reft C; Weichselbaum R; Panje WR
    Laryngoscope; 1988 May; 98(5):561-3. PubMed ID: 3129630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.
    Smith BD; Smith GL; Carter D; DiGiovanna MP; Kasowitz KM; Sasaki CT; Haffty BG
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):780-5. PubMed ID: 11448349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [High-dose preoperative radiotherapy of primary inoperable oropharyngeal cancer].
    Fassbender T; Majer M; Hübener KH; Schmidt B; Schmelzle R
    Strahlenther Onkol; 1987 Sep; 163(9):573-8. PubMed ID: 3660221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Results of irradiation by telecobalt at low dose rat, up to March 1973 (author's transl)].
    Pierquin B; Baillet F; Raynal M; Marinello G; Turgard I
    J Radiol Electrol Med Nucl; 1974; 55(6-7):515-8. PubMed ID: 4425132
    [No Abstract]   [Full Text] [Related]  

  • 47. [Differential effect of low output radiotherapy].
    Pierquin B
    Bull Acad Natl Med; 1970 Jun; 154(23):579-83. PubMed ID: 4922866
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment results of combined high-dose preoperative radiotherapy and surgery for oropharyngeal cancer.
    Rabuzzi DD; Mickler AS; Clutter DJ; Chung CT; Sagerman RH
    Laryngoscope; 1982 Sep; 92(9 Pt 1):989-92. PubMed ID: 7121170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Need for objective patient selection criteria for palliative radiotherapy in advanced head and neck cancer.
    Chilukuri S; Laskar SG; Murthy V; Agarwal JP; Budrukkar A; Dinshaw KA
    Radiother Oncol; 2008 May; 87(2):308; author reply 309. PubMed ID: 18417233
    [No Abstract]   [Full Text] [Related]  

  • 50. [Radiation therapy of epipharyngeal cancer].
    Sasauchi S; Yamada S; Kusakari J; Kikuchi A
    Rinsho Hoshasen; 1987 Jan; 32(1):33-6. PubMed ID: 3573359
    [No Abstract]   [Full Text] [Related]  

  • 51. [Differential effects of continual (or semi-continual) low output irradiation of epidermoid carcinoma (preliminary note)].
    Pierquin B
    J Radiol Electrol Med Nucl; 1970; 51(8):533-6. PubMed ID: 5488497
    [No Abstract]   [Full Text] [Related]  

  • 52. [ORL brachytherapy. Brachytherapy of squamous cell carcinoma of the oropharynx].
    Hoffstetter S
    Bull Cancer Radiother; 1995; 82(2):191-8. PubMed ID: 7546890
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy.
    Chen J; Pappas L; Moeller JH; Rankin J; Sharma PK; Bentz BG; Fang LC; Hayes JK; Shrieve DC; Hitchcock YJ
    Head Neck; 2007 Apr; 29(4):362-9. PubMed ID: 17163468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Integrative radiomodifying therapy of malignant oropharyngeal tumors].
    Bykov VL
    Vestn Otorinolaringol; 1988; (1):73-5. PubMed ID: 3354153
    [No Abstract]   [Full Text] [Related]  

  • 55. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma.
    Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radiotherapy of malignant neoplasms of the maxillary sinus. (Clinico-statistical contribution)].
    Corinaldesi A; Cecchetti E; Roversi R; Cammoranesi L
    Radiobiol Radioter Fis Med; 1968; 23(3):149-86. PubMed ID: 4307164
    [No Abstract]   [Full Text] [Related]  

  • 57. Radiotherapy for postoperative persistent cancer of the head and neck.
    Hoover SV; Moss WT
    Otolaryngol Clin North Am; 1974 Feb; 7(1):175-92. PubMed ID: 4360034
    [No Abstract]   [Full Text] [Related]  

  • 58. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma.
    Silva P; West CM; Slevin N; Valentine H; Ryder WD; Hampson L; Bibi R; Sloan P; Thakker N; Homer J; Hampson I
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):133-40. PubMed ID: 17459603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment results in nasopharyngeal cancer following cobalt teletherapy].
    Ziegler F; Metzger H; Hübener KH
    Strahlentherapie Sonderb; 1984; 78():90-2. PubMed ID: 6729914
    [No Abstract]   [Full Text] [Related]  

  • 60. Irradiation scheme using three daily fractions in the radiation therapy of pharyngeal and oral carcinomas.
    Durkovský J; Jancina J; Siracká E; Krajci M
    Neoplasma; 1984; 31(2):213-22. PubMed ID: 6717690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.